2008 Landis award lecture inflammation and the autodigestion hypothesis

Microcirculation

Volumn 16, Issue 4, 2009, Pages 289-306

  Schmid Schönbein, Geert W ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Hypertension; Inflammation; Matrix metalloproteinases; Microcirculation; Multi organ failure; Pancreatic enzymes; Shock

Indexed keywords

BIOLOGICAL MARKER; GLUCOSE; INSULIN; INSULIN RECEPTOR; MATRIX METALLOPROTEINASE; MEMBRANE RECEPTOR; PANCREAS ENZYME;

CELL FUNCTION; DIGESTION; ENZYME ACTIVITY; ENZYME INHIBITION; GLUCOSE TRANSPORT; HUMAN; INFLAMMATION; INSULIN RESISTANCE; INTESTINE; INTESTINE INJURY; LIPOLYSIS; METABOLIC DISORDER; MULTIPLE ORGAN FAILURE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS; PLASMA; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW; SEPTIC SHOCK; SHOCK; TISSUE INJURY; TISSUE REPAIR; ARTICLE; ENZYMOLOGY; METABOLISM; PATHOLOGY;

BIOLOGICAL MARKERS; HUMANS; INFLAMMATION; INTESTINES; MATRIX METALLOPROTEINASES; PANCREAS;

EID: 67650287245     PISSN: 10739688     EISSN: 15498719     Source Type: Journal    
DOI: 10.1080/10739680902801949     Document Type: Review

References (131)

1. Abraham CR, Potter H. (1989). The protease inhibitor, alpha 1-antichymotrypsin, is a component of the brain amyloid deposits in normal aging and Alzheimer's disease. Ann Med 21:77-81.
2. Acosta JA, Hoyt DB, Schmid-Schonbein GW, Hugli TE, Anjaria DJ, Frankel DA, Coimbra R. (2006). Intraluminal pancreatic serine protease activity, mucosal permeability, and shock: a review. Shock 26:3-9.
3. Adams CA, Jr, Xu DZ, Lu Q, Deitch EA. (2001). Factors larger than 100 kd in post-hemorrhagic shock mesenteric lymph are toxic for endothelial cells. Surgery 129:351-363.
4. Ahmad E, Steinberg SM, Goldin L, Hess CJ, Caporaso N, Kreitman RJ, Wiestner A, Wilson W, White T, Marti G, Stetler-Stevenson M. (2008). Immunophenotypic features distinguishing familial chronic lymphocytic leukemia from sporadic chronic lymphocytic leukemia. Cytom B Clin Cytom 74:221-226.
5. Arndt H, Smith CW, Granger DN. (1993). Leukocy-te-endothelial cell adhesion in spontaneously hypertensive and normotensive rats. Hypertension 21:667-673.
6. Arroyo AG, Genis L, Gonzalo P, Matias-Roman S, Pollan A, Galvez BG. (2007). Matrix metalloprotei-nases: new routes to the use of MT1-MMP as a therapeutic target in angiogenesis-related disease. Curr Pharm Des 13:1787-1802.
7. Beaudeux JL, Giral P, Bruckert E, Foglietti MJ, Chapman MJ. (2004). Matrix metalloproteinases, inflammation, and atherosclerosis: therapeutic perspectives. Clin Chem Lab Med 42:121-131.
8. Biffl WL, Moore EE, Moore FA. (1995). Gut-derived mediators of multiple organ failure: platelet-activating factor and interleukin-6. Br J Hosp Med 54: 134-138.
9. Boonacker E, Van Noorden CJ. (2001). Enzyme cytochemical techniques for metabolic mapping in living cells, with special reference to proteolysis. J Histochem Cytochem 49:1473-1486.
10. Brundula V, Rewcastle NB, Metz LM, Bernard CC, Yong VW. (2002). Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis. Brain 125:1297-1308.
11. Bursztyn M, Ben-Ishay D, Gutman A. (1992). Insulin resistance in spontaneously hypertensive rats but not in deoxycorticosterone-salt or renal vascular hypertension. J Hypertens 10:137-142.
12. Bush KT, Tsukamoto T, Nigam SK. (2000). Selective degradation of E-cadherin and dissolution of E-cadherin-catenin complexes in epithelial ischemia. Am J Physiol Renal Physiol 278:F847-F852.
13. Chang TW. (1997). Improvement of survival from hemorrhagic shock by enterectomy in rats: finding to implicate the role of the gut for irreversibility of hemorrhagic shock. J Trauma 42:223-230.
14. Childs EW, Udobi KF, Hunter FA. (2005). Hypothermia reduces microvascular permeability and reactive oxygen species expression after hemorrhagic shock. J Trauma 58:271-277.
15. Cho KO, La HO, Cho YJ, Sung KW, Kim SY. (2006). Minocycline attenuates white matter damage in a rat model of chronic cerebral hypoperfusion. J Neurosci Res 83:285-291.
16. Chung AW, Booth AD, Rose C, Thompson CR, Levin A, van Breemen C. (2008). Increased matrix metalloproteinase 2 activity in the human internal mammary artery is associated with ageing, hypertension, diabetes, and kidney dysfunction. J Vasc Res 45:357-362.
17. Coimbra R, Hoyt D, Winchell R, Simons R, Fortlage D, Garcia J. (1996). The ongoing challenge of retroperitoneal vascular injuries. Am J Surg 172: 541-544; discussion, 545.
18. Curry S, Brick P, Franks NP. (1999). Fatty acid binding to human serum albumin: new insights from crystallographic studies. Biochim Biophys Acta 1441:131-140.
19. Dayal SD, Hauser CJ, Feketeova E, Fekete Z, Adams JM, Lu Q, Xu DZ, Zaets S, Deitch EA. (2002). Shock mesenteric lymph-induced rat polymorphonuclear neutrophil activation and endothelial cell injury is mediated by aqueous factors. J Trauma 52:1048-1055; discussion, 1055.
20. Deitch ED, Shi HP, Lu Q, Feketeova E, Xu DZ. (2003). Serine proteases are involved in the pathogenesis of trauma-hemorrhagic shoch-induced gut and lung injury. Shock 19:452-456.
21. del Zoppo GJ, Milner R, Mabuchi T, Hung S, Wang X, Berg GI, Koziol JA. (2007). Microglial activation and matrix protease generation during focal cerebral ischemia. Stroke 38:646-651.
22. DeLano FA, Balete R, Schmid-Schonbein GW. (2005). Control of oxidative stress in microcirculation of spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 288:H805-H812.
23. DeLano FA, Hoyt DB, Schmid-Schonbein GW. (2007). The auto-digestion hypothesis: blockade of pancreatic digestive enzymes in the lumen of the intestine during hemorrhagic shock reduces mortality. FASEB J 21:421 (Abstract).
24. DeLano FA, Parks DA, Ruedi JM, Babior BM, Schmid-Schonbein GW. (2006). Microvascular display of xanthine oxidase and NADPH oxidase in the spontaneously hypertensive rat. Microcirculation 13:551-566.
25. DeLano FA, Schmid-Schonbein GW. (2008). Proteinase activity and receptor cleavage: mechanism for insulin resistance in the spontaneously hypertensive rat. Hypertension 52:415-423.
26. Emerit I, Garban F, Vassy J, Levy A, Filipe P, Freitas J. (1996). Superoxide-mediated clastogen-esis and anticlastogenic effects of exogenous superoxide dismutase. Proc Natl Acad Sci USA 93: 12799-12804.
27. Eppihimer MJ, Granger DN. (1997). Ischemia/ reperfusion-induced leukocyte-endothelial interactions in postcapillary venules. Shock 8:16-25.
28. Fitzal F, Delano FA, Young C, Rosario HS, Junger WG, Schmid-Schonbein GW. (2003). Pancreatic enzymes sustain systemic inflammation after an initial endotoxin challenge. Surgery 134:446-456.
29. Fitzal F, DeLano FA, Young C, Rosario HS, Schmid-Schonbein GW. (2002). Pancreatic protease inhibition during shock attenuates cell activation and peripheral inflammation. J Vasc Res 39: 320-329.
30. Fitzal F, DeLano FA, Young C, Schmid-Schonbein GW. (2004). Improvement in early symptoms of shock by delayed intestinal protease inhibition. Arch Surg 139:1008-1016.
31. Fitzal F, Kistler E, Mitsuoka H, Hugli TE, Schmid-Schonbein GW. (2005). A new hypothesis for the origin of shock: Self-digestion of the ischemic intestine by pancreatic enzymes. In: Pitzer JA (Ed.), Progress in Inflammation. Nova Science Pub.
32. Fruchterman TM, Spain DA, Wilson MA, Harris PD, Garrison RN. (1998). Selective microvascular endothelial cell dysfunction in the small intestine following resuscitated hemorrhagic shock. Shock 10: 417-422.
33. Fukuda S, Fini CA, Mabuchi T, Koziol JA, Egglest-on LL, Jr, del Zoppo GJ. (2004). Focal cerebral ischemia induces active proteases that degrade microvascular matrix. Stroke 35:998-1004.
34. Fukuda T, Hata N. (1969). Mechanisms of endotoxin shock in rats and the anti-endotoxic effect of glucocorticoids and endotoxin-conditioning. Jap J Physiol 19:509-520.
35. Galis ZS, Khatri JJ. (2002). Matrix metalloprotei-nases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res 90:251-262.
36. Garcia RA, Pantazatos DP, Gessner CR, Go KV, Woods VL, Jr, Villarreal FJ. (2005). Molecular interactions between matrilysin and the matrix metalloproteinase inhibitor doxycycline investigated by deuterium exchange mass spectrometry. Mol Pharmacol 67:1128-1136.
37. Garcia Soriano F, Liaudet L, Marton A, Hasko G, Batista Lorigados C, Deitch EA, Szabo C. (2001). Inosine improves gut permeability and vascular reactivity in endotoxic shock. Crit Care Med 29: 703-708.
38. Gasche Y, Soccal PM, Kanemitsu M, Copin JC. (2006). Matrix metalloproteinases and diseases of the central nervous system with a special emphasis on ischemic brain. Front Biosci 11:1289-1301.
39. George SK, Meyer TN, Abdeen O, Bush KT, Nigam SK. (2004). Tunicamycin preserves intercellular junctions, cytoarchitecture, and cell-substratum interactions in ATP-depleted epithelial cells. Biochem Biophys Res Commun 322:223-231.
40. Glenn TM, Herlihy BL, Ferfuson WW, Lefer AM. (1972). Protective effect of pancreatic duct ligation in splanchnic ischemia shock. Am J Physiol 222: 1278-1284.
41. Go VLW, Dimagno EP, Gardner JD, Lebenthal E, Reber HA, Scheele GA. (1993). The Pancreas. Biology, Pathobiology, and Disease (pp. 1-1176). New York: Raven Press.
42. Griffin MO, Jinno M, Miles LA, Villarreal FJ. (2005). Reduction of myocardial infarct size by doxycycline: a role for plasmin inhibition. Mol Cell Biochem 270:1-11.
43. Harlan JM, Winn RK. (2002). Leukocyte-endothe-lial interactions: clinical trials of anti-adhesion therapy. Crit Care Med 30:S214-S219.
44. Healey MA, Samphire J, Hoyt DB, Liu F, Davis R, Loomis WH. (2001). Irreversible shock is not irreversible: a new model of massive hemorrhage and resuscitation. J Trauma 50:826-834.
45. Hinshaw LB. (1996). Sepsis/septic shock: participation of the microcirculation: an abbreviated review. Crit Care Med 24:1072-1078.
46. Hulman S, Falkner B, Freyvogel N. (1993). Insulin resistance in the conscious spontaneously hypertensive rat: euglycemic hyperinsulinemic clamp study. Metab Clin Exp 42:14-18.
47. Jarrar D, Wang P, Cioffi WG, Bland KI, Chaudry IH. (2000). Critical role of oxygen radicals in the initiation of hepatic depression after trauma hemorrhage. J Trauma 49:879-885.
48. Kaiser VL, Sifri ZC, Senthil M, Dikdan GS, Lu Q, Xu DZ, Deitch EA. (2005). Albumin peptide: a molecular marker for trauma/hemorrhagic-shock in rat mesenteric lymph. Peptides 26:2491-2499. Epub 2005 Jun 8.
49. Kien ND, Antognini JF, Reilly DA, Moore PG. (1996). Small-volume resuscitation using hypertonic saline improves organ perfusion in burned rats. Anesth Analges 83:782-788.
50. Kistler EB, Hugli TE, Schmid-Schonbein GW. (2000). The pancreas as a source of cardiovascular cell activating factors. Microcirculation 7:183-192.
51. Kistler EB, Lefer AM, Hugli TE, Schmid-Schonbein GW. (2000). Plasma activation during splanchnic arterial occlusion shock. Shock 14:30-34.
52. Kolev K, Skopal J, Simon L, Csonka E, Machovich R, Nagy Z. (2003). Matrix metalloproteinase-9 expression in post-hypoxic human brain capillary endothelial cells: H2O2 as a trigger and NF-kappaB as a signal transducer. Thromb Haemost 90: 528-537.
53. Korhonen H, Pihlanto A. (2003). Food-derived bioactive peptides-opportunities for designing future foods. Curr Pharm Des 9:1297-1308.
54. Kramp WJ, Waldo S, Schmid-Schonbein GW, Hoyt D, Coimbra R, Hugli TE. (2003). Characterization of two classes of pancreatic shock factors: functional differences exhibited by hydrophilic and hydrophobic shock factors. Shock 20:356-362.
55. Labat-Robert J, Kern P, Robert L. (1992). Biomar-kers of connective tissue aging: biosynthesis of fibronectin, collagen type III, and elastase. Ann N YAcad Sci 673:16-22.
56. Lee CZ, Yao JS, Huang Y, Zhai W, Liu W, Guglielmo BJ, Lin E, Yang GY, Young WL. (2006). Dose-response effect of tetracyclines on cerebral matrix metalloproteinase-9 after vascular endothelial growth factor hyperstimulation. J Cereb Blood Flow Metab 26:1157-1164.
57. Lefer AM. (1974). Myocardial depressant factor and circulatory shock. Klinische Wochenschrift 52: 358-370.
58. Lefer AM. (1970). Role of a myocardial depressant factor in the pathogenesis of circulatory shock. Fed Proc 29:1836-1847.
59. Lehoux S, Lemarie CA, Esposito B, Lijnen HR, Tedgui A. (2004). Pressure-induced matrix metalloproteinase-9 contributes to early hypertensive remodeling. Circulation 109:1041-1047.
60. Leonardo CC, Eakin AK, Ajmo JM, Collier LA, Pennypacker KR, Strongin AY, Gottschall PE. (2008). Delayed administration of a matrix metal-loproteinase inhibitor limits progressive brain injury after hypoxia-ischemia in the neonatal rat. J Neu-roinflammation 5:34.
61. Ley K, Gaehtgens P. (1987). Microcirculation disorders in shock]. Klin Anasthesiol Intensivther 33: 19-36.
62. Lijnen HR. (2002). Extracellular proteolysis in the development and progression of atherosclerosis. Biochem Soc Trans 30:163-167.
63. Lim HH, DeLano FA, Schmid-Schonbein GW. (2001). Life and death cell labeling in the microcirculation of the spontaneously hypertensive rat. J Vasc Res 38:228-236.
64. Luttun A, Dewerchin M, Collen D, Carmeliet P. (2000). The role of proteinases in angiogenesis, heart development, restenosis, atherosclerosis, myocardial ischemia, and stroke: insights from genetic studies. Curr Atheroscler Rep 2:407-416.
65. Manabe T, Suzuki T, Honjo I. (1978). Role of the pancreas in organ blood flow during shock. Surg Gynecol Obstet 146:577-582.
66. Martin MA, Monnnai M, Otani H. (2000). Isolation and characterization of a cytotoxic pentapeptide, k-casecidin, from bovine K-casein digested with bovine trypsin. Anim Sci J 71:197-207.
67. Martin MA, Otani H. (2001). Antimicrobial and cytotoxic peptides released from milk proteins by the action of mammalian gastrointestinal proteinases. Curr Res Adv Agric Biol Chem 1:23-36.
68. Mathison JC, Wolfson E, Ulevitch RJ. (1988). Participation of tumor necrosis factor in the mediation of Gram-negative bacterial lipopolysaccharide- induced injury in rabbits. J Clin Invest 81: 1925-1937.
69. McCord JM, Fridovich I. (1969). Superoxide dis-mutase: an enzymatic function for erthryocuprein (hemocuprein). J Biol Chem 244:6049-6055.
70. McCuskey RS. (1999). Hepatic and splanchnic microvascular responses to inflammation and shock. Hepato-Gastroenterol 46(Suppl 2):1464-1467.
71. McMillen MA, Huribal M, Sumpio B. (1993). Common pathway of endothelial-leukocyte interaction in shock, ischemia, and reperfusion. Am J Surg 166:557-562.
72. Meisel H, FitzGerald RJ. (2003). Biofunctional peptides from milk proteins: mineral binding and cytomodulatory effects. Curr Pharm Des 9: 1289-1295.
73. Migeotte I, Riboldi E, Franssen JD, Gregoire F, Loison C, Wittamer V, Detheux M, Robberecht P, Costagliola S, Vassart G, Sozzani S, Parmentier M, Communi D. (2005). Identification and characterization of an endogenous chemotactic ligand specific for FPRL2. J Exp Med 201:83-93.
74. Mitsuoka H, Kistler EB, Schmid-Schonbein GW. (2000). Generation of in vivo activating factors in the ischemic intestine by pancreatic enzymes. Proc Natl Acad Sci USA 97:1772-1777.
75. Mitsuoka H, Kistler EB, Schmid-Schonbein GW. (2002). Protease inhibition in the intestinal lumen: attenuation of systemic inflammation and early indicators of multiple organ failure in shock. Shock 17:205-209.
76. Mota-Filipe H, McDonald MC, Cuzzocrea S, Thiemermann C. (1999). A membrane-permeable radical scavenger reduces the organ injury in hemorrhagic shock. Shock 12:255-261.
77. Newby AC. (2005). Dual role of matrix metallopro-teinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Physiol Rev 85:1-31.
78. O'Connor DT, Takiyyuddin MA, Printz MP, Dinh TQ, Barbosa JA, Rozansky DJ, Mahata SK, Wu H, Kennedy BP, Ziegler MG, Wright FA, Schlager G, Parmer RJ. (1999). Catecholamine storage vesicle protein expression in genetic hypertension. Blood Press 8:285-295.
79. Ooyama T, Sakamato H. (1995). Elastase in the prevention of arterial aging and the treatment of atherosclerosis. Ciba Found Symp 192:307-317; discussion, 318-320.
80. Otani H, Hata I. (1995). Inhibition of proliferative responses of mouse spleen lymphocytes and rabbit Peyer's patch cells by bovine milk caseins and their digests. J Dairy Res 62:339-348.
81. Parker F, Migliore-Samour D, Floc'h F, Zerial A, Werner GH, Jolles J, Casaretto M, Zahn H, Jolles P. (1984). Immunostimulating hexapeptide from human casein: amino acid sequence, synthesis, and biological properties. Eur J Biochem 145: 677-682.
82. Peitzman AB, Billiar TR, Harbrecht BG, Kelly E, Udekwu AO, Simmons RL. (1995). Hemorrhagic shock. Curr Prob Surg 32:925-1002.
83. Penn AH. (2005). Digestive enzymes in the generation of cytotoxic mediators during shock. University of California-San Diego, Ph.D. Thesis.
84. Penn AH, Hugli TE, Schmid-Schonbein GW. (2007). Pancreatic enzymes generate cytotoxic mediators in the intestine. Shock 27:296-304.
85. Penn AH, Schmid-Schonbein GW. (2008). The intestine as source of cytotoxic mediators in shock: free fatty acids and degradation of lipid-binding proteins. Am J Physiol Heart Circ Physiol 294: H1779-H1792.
86. Pillai S, Oresajo C, Hayward J. (2005). Ultraviolet radiation and skin aging: roles of reactive oxygen species, inflammation and protease activation, and strategies for prevention of inflammation-induced matrix degradation-a review. Int J Cosmet Sci 27: 17-34.
87. Prewitt RL, Cardoso SS, Wood WB. (1986). Prevention of arteriolar rarefaction in the spontaneously hypertensive rat by exposure to simulated high altitude. JHypertens 4:735-740.
88. Raffetto JD, Khalil RA. (2008). Matrix metallopro-teinases and their inhibitors in vascular remodeling and vascular disease. Biochem Pharmacol 75: 346-359.
89. Roghanian A, Sallenave JM. (2008). Neutrophil elastase (NE) and NE inhibitors: canonical and noncanonical functions in lung chronic inflammatory diseases (cystic fibrosis and chronic obstructive pulmonary disease). J Aerosol Med Pulm Drug Deliv 21:125-144.
90. Rollwagen FM, Li YY, Pacheco ND, Dick EJ, Kang YH. (2000). Microvascular effects of oral interleu-kin-6 on ischemia/reperfusion in the murine small intestine. Am J Pathol 156:1177-1182.
91. Romero-Perez D, Fricovsky E, Yamasaki KG, Griffin M, Barraza-Hidalgo M, Dillmann W, Villar-real F. (2008). Cardiac uptake of minocycline and mechanisms for in vivo cardioprotection. J Am Coll Cardiol 52:1086-1094.
92. Rosario HS, Waldo SW, Becker SA, Schmid-Schonbein GW. (2004). Pancreatic trypsin increases matrix metalloproteinase-9 accumulation and activation during acute intestinal ischemia-reperfusion in the rat. Am J Pathol 164:1707-1716.
93. Roumen RM, Hendriks T, Wevers RA, Goris JA. (1993). Intestinal permeability after severe trauma and hemorrhagic shock is increased without relation to septic complications. Arch Surg 128:453-457.
94. Rubanyi GM. (1998). Nitric oxide and circulatory shock. Adv Exp Med Biol 454:165-172.
95. Russell DH, Barreto JC, Klemm K, Miller TA. (1995). Hemorrhagic shock increases gut macro-molecular permeability in the rat. Shock 4:50-55.
96. Scheidler N. (2007). The Impact of Endothelial Mechanotransduction on Capillary Network Perfusion. University of California-San Diego, Ph.D. Thesis.
97. Schmid-Schonbein GW. (2006). Analysis of inflammation. Annu Rev Biomed Eng 8:93-131.
98. Schmid-Schonbein GW, Hugli TE, Kistler EB, Sofianos A, Mitsuoka H. (2001). Pancreatic enzymes and microvascular cell activation in multi-organ failure. Microcirculation 8:5-14.
99. Schmid-Schonbein GW, Kistler EB, Hugli TE. (2001). Mechanisms for cell activation and its consequences for biorheology and microcirculation: multi-organ failure in shock. Biorheology 38: 185-201.
100. Schmid-Schonbein GW, Seiffge D, DeLano FA, Shen K, Zweifach BW. (1991). Leukocyte counts and activation in spontaneously hypertensive and normotensive rats. Hypertension 17:323-330.
101. Schober M, Howe PR, Sperk G, Fischer-Colbrie R, Winkler H. (1989). An increased pool of secretory hormones and peptides in adrenal medulla of stroke-prone spontaneously hypertensive rats. Hypertension 13:469-474.
102. Sechi LA, Griffin CA, Giacchetti G, Zingaro L, Catena C, Bartoli E, Schambelan M. (1996). Abnormalities of insulin receptors in spontaneously hypertensive rats. Hypertension 27:955-961.
103. Shen K, Sung KL, Whittemore DE, DeLano FA, Zweifach BW, Schmid-Schonbein GW. (1995). Properties of circulating leukocytes in spontaneously hypertensive rats. Biochem Cell Biol 73:491-500.
104. Smedegard G, Cui LX, Hugli TE. (1989). Endo-toxin-induced shock in the rat. A role for C5a. Am J Pathol 135:489-497.
105. Spinale FG. (2002). Matrix metalloproteinases: regulation and dysregulation in the failing heart. Circ Res 90:520-530.
106. Suematsu M, Suzuki H, Delano FA, Schmid-Schonbein GW. (2002). The inflammatory aspect of the microcirculation in hypertension: oxidative stress, leukocytes/endothelial interaction, apoptosis. Microcirculation 9:259-276.
107. Suematsu M, Suzuki H, Tamatani T, Iigou Y, DeLano FA, Miyasaka M, Forrest MJ, Kannagi R, Zweifach BW, Ishimura Y, Schmid-Schonbein GW. (1995). Impairment of selectin-mediated leukocyte adhesion to venular endothelium in spontaneously hypertensive rats. J Clin Invest 96:2009-2016.
108. Suzuki H, DeLano FA, Jamshidi N, Katz D, Mori M, Kosaki K, Gottlieb RA, Ishii H, Schmid-Schonbein GW. (1999). Enhanced DNA fragmentation in the thymus of spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 276:H2135-H2140.
109. Suzuki H, Schmid-Schonbein GW, Suematsu M, DeLano FA, Forrest MJ, Miyasaka M, Zweifach BW. (1994). Impaired leukocyte-endothelial cell interaction in spontaneously hypertensive rats. Hypertension 24:719-727.
110. Suzuki H, Swei A, Zweifach BW, Schmid-Schonbein GW. (1995). In vivo evidence for microvascular oxidative stress in spontaneously hypertensive rats. Hydroethidine microfluorography. Hypertension 25: 1083-1089.
111. Suzuki T, Motoyama T, Sato R. (1980). Periarteritis nodosa in spontaneously hypertensive rats. Acta Pathol Jpn 30:907-912.
112. Takiyyuddin MA, De Nicola L, Gabbai FB, Dinh TQ, Kennedy B, Ziegler MG, Sabban EL, Parmer RJ, O'Connor DT. (1993). Catecholamine secretory vesicles. Augmented chromogranins and amines in secondary hypertension. Hypertension 21:674-679.
113. Thiagarajan RR, Winn RK, Harlan JM. (1997). The role of leukocyte and endothelial adhesion molecules in ischemia-reperfusion injury. Thromb Haemost 78:310-314.
114. Tompkins SD, Gregory S, Hoyt DB, Ozkan AN. (1990). In vitro inhibition of IL-2 biosynthesis in activated human peripheral blood mononuclear cells by a trauma-induced glycopeptide. Immunol Lett 23:205-209.
115. Tran ED, Schmid-Schonbein GW. (2007). An in-vivo analysis of capillary stasis and endothelial apoptosis in a model of hypertension. Microcirculation 1-12.
116. Uchiba M, Okajima K, Murakami K, Okabe H, Takatsuki K. (1995). Endotoxin-induced pulmonary vascular injury is mainly mediated by activated neutrophils in rats. Thromb Res 78:117-125.
117. Vender RL. (1996). Therapeutic potential of neu-trophil-elastase inhibition in pulmonary disease. J Invest Med 44:531-539.
118. Vollmar B. (1995). Microcirculation and oxygen supply to the liver in hemorrhagic shock and sepsis]. Anasthesiol Intensivmed Notfallmed Schmerzther 30(Suppl 1):S52-S54.
119. Waldo SW, Rosario HS, Penn AH, Schmid-Schonbein GW. (2003). Pancreatic digestive enzymes are potent generators of mediators for leukocyte activation and mortality. Shock 20:138-143.
120. Wang Y, Luo W, Reiser G. (2008). Trypsin and trypsin-like proteases in the brain: proteolysis and cellular functions. Cell Mol Life Sci 65:237-252.
121. Watanabe N, Ikeda U. (2004). Matrix metalloproteinases and atherosclerosis. Curr Atheroscler Rep 6:112-120.
122. Wattanasirichaigoon S, Menconi MJ, Delude RL, Fink MP. (1999). Effect of mesenteric ischemia and reperfusion or hemorrhagic shock on intestinal mucosal permeability and ATP content in rats. Shock 12:127-133.
123. Waxman K. (1996). Shock: ischemia, reperfusion, and inflammation. New Horiz 4:153-160.
124. Wettstein R, Tsai AG, Erni D, Winslow RM, Intaglietta M. (2003). Resuscitation with polyethylene glycol-modified human hemoglobin improves microcirculatory blood flow and tissue oxygenation after hemorrhagic shock in awake hamsters. Crit Care Med 31:1824-1830.
125. Winn RK, Mihelicic D, Vedder NB, Sharar SR, Harlan JM. (1993). Monoclonal antibodies to leukocyte and endothelial adhesion molecules attenuate ischemia-reperfusion injury. Behring Institute Mitteilungen 119:229-237.
126. Winn RK, Sharar SR, Vedder NB, Harlan JM. (1995). Leukocyte and endothelial adhesion molecules in ischaemia/reperfusion injuries. Ciba Found Symp 189:63-71; discussion 72-76:77-78.
127. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. (1990). CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS-binding protein. Science 249:1431-1433.
128. Yong VW, Zabad RK, Agrawal S, Goncalves Dasilva A, Metz LM. (2007). Elevation of matrix metallo-proteinases (MMPs) in multiple sclerosis and impact of immunomodulators. J Neurol Sci 259:79-84.
129. Zimmet P, Magliano D, Matsuzawa Y, Alberti G, Shaw J. (2005). The metabolic syndrome: a global public health problem and a new definition. J Atheroscler Thromb 12:295-300.
130. Zweifach BW, Kovalcheck S, DeLano F, Chen P. (1981). Micropressure-flow relationships in a skeletal muscle of spontaneously hypertensive rats. Hypertension 3:601-614.
131. Zweifach BW, Lipowsky HH. (1984). Pressure-flow relations in blood and lymph microcirculation. In: Renkin EM, Michel CC, eds. Handbook of Physiology, Section 2: The Cardiovascular System (pp. 251-307). Bethesda, Maryland, USA: American Physiological Society.